Anti-malarial Drugs Market to See Booming Growth with Ipca Laboratorie, Cadila Healthcare, Merck Group, Pfizer, GlaxoSmithKline, Cipla

Different types of drugs such as quinine, chloroquine, mefloquine, proguanil, primaquine, and others are used in the treatment of malaria. Moreover, some combination drugs such as Pyrimethamine & sulfadoxine, Artemether & lumefantrine, and others are also prescribed for treating the disease. According to the World Health Organization (WHO), around 91 countries and territories are at the risk of malaria transmission.

Malaria is considered as a life-threatening disease affecting large number of population across the world. According to the World Health Organization (WHO), in 2018, around 228 million estimated cases of malaria were diagnosed, globally. Moreover, global death toll due to malaria reached 405,000 in 2018 and an estimated 219 million cases were diagnosed in 2017. Sub-Saharan Africa is the most affected region due to malaria and according to WHO estimation, the region accounted for 93% of malaria cases among all the global cases. Thus, the increasing incidence of malaria in the world is expected to drive growth of the anti-malaria drugs market during the forecast period.

Get Free Sample Report + All Related Graphs & Charts @ https://www.coherentmarketinsights.com/insight/request-sample/3726

Moreover, various pharmaceutical companies are actively participating in research and development activities, in order to develop novel drug entity for treatment of malaria. For instance, in November 2017, Novartis Pharmaceuticals initiated phase 2 clinical trial to study the safety of the maximum dose of the investigational drug KAE609 in adult patients with uncomplicated malaria. The study is estimated to be completed in April 30, 2020. Such, increasing number of lead candidates is expected to contribute to growth of the global anti-malaria drugs market in the near future.

Detailed Segmentation:

Global Anti-malarial Drugs Market, By Drug Class:
Aminoquinolines
Quinoline-methanol (4-quinolinemethanols)
Cinchona Alkaloids
Biguanides
Sulfonamides and sulfones
Others
Global Anti-malarial Drugs Market, By Route of Administration:
Oral
Injectable
Global Anti-malarial Drugs Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

The global anti-malarial drugs market is expected to exhibit a CAGR of 4.4% during the forecast period (2019–2027), owing to increasing initiatives by various research to develop novel drugs to treat malaria. For instance, in October 2018, Armed Forces Research Institute of Medical Sciences, Thailand, initiated phase 4 clinical trial to determine the efficacy assessment of Pyronaridine-Artesunate (Pyramax) and new drug combinations with Atovaquone-Proguanil for the treatment of uncomplicated P. Falciparum malaria in Cambodia. The study is estimated to be completed on June 30, 2021.

Buy this research report @ https://www.coherentmarketinsights.com/insight/buy-now/3726

Furthermore, increasing demand for anti-malaria drugs in key regions such as India and other South-east Asian countries, and high prevalence of malaria in these countries are expected to drive growth of the anti-malarial drugs market. For instance, according to WHO, in 2017, around 3 million cases of malaria were diagnosed in India. Moreover, WHO stated that in 2019, India accounted for 21% of total deaths in South-east Asia region.

Major players operating in the global anti-malarial drugs market include Ipca Laboratories Ltd., Zydus Cadila, Merck KGaA, Pfizer, GlaxoSmithKline Plc., Cipla Ltd, Ranbaxy Laboratories, Novartis AG, Alvizia Health Care, Bayer AG, and Roche Inc

Coherent Market Insights 1001 4th Ave,
#3200 Seattle, WA 98154,U.S.
Phone: US +1-206-701-6702/UK +44-020 8133 4027
Email: sales@coherentmarketinsights.com

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.